Dennis H. Giesing
2021
In 2021, Dennis H. Giesing earned a total compensation of $3.5M as Chief Development Officer at Immunome.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $84,318 |
| Option Awards | $3,055,236 |
| Salary | $306,971 |
| Other | $2,969 |
| Total | $3,499,494 |
Giesing received $3.1M in option awards, accounting for 87% of the total pay in 2021.
Giesing also received $50K in bonus, $84.3K in non-equity incentive plan, $307K in salary and $3K in other compensation.
Rankings
In 2021, Dennis H. Giesing's compensation ranked 3,828th out of 12,415 executives tracked by ExecPay. In other words, Giesing earned more than 69.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,828 out of 12,415 | 69th |
Division Manufacturing | 1,568 out of 5,508 | 72nd |
Major group Chemicals And Allied Products | 640 out of 2,378 | 73rd |
Industry group Drugs | 569 out of 2,099 | 73rd |
Industry Pharmaceutical Preparations | 398 out of 1,549 | 74th |
Source: SEC filing on April 20, 2023.
Giesing's colleagues
We found two more compensation records of executives who worked with Dennis H. Giesing at Immunome in 2021.